About Althea Technologies
Althea Technologies is a Healthcare company based in San Diego (United States) founded in 1998 by Francois Ferre, and was acquired by Ajinomoto in March 2013. Clinical drugs and vaccines are manufactured and distributed via contracts. Althea Technologies has raised $23 million across 1 funding round from investors including Ajinomoto and Telegraph Hill Partners. Its chief executive, as recorded, is Francois Ferre. Althea Technologies offers products and services including Smålån Service, Forbrukslån Service, and Refinansiering Service. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and Drug Development. Its competitors include Nephron Pharmaceuticals, Kardigan and AmbioPharm; 3 of its 3 listed competitors have raised funding.
Company details
Althea Technologies was founded in 1998 in San Diego, United States, and operates in the pharmaceutical sector as a contract manufacturer and distributor of clinical drugs and vaccines. Services provided include aseptic syringe filling, lyophilization, release testing, clinical packaging, and stability programs, supporting various clinical needs in the industry.
- Headquarters San Diego, United States
- Founders Francois Ferre
- Stage Acquired
- SectorsHealthcare
- Website altheatech.com
- Social LinkedIn
- Acquired by Ajinomoto (Mar 2013)
Products & Services of Althea Technologies
Althea Technologies offers a comprehensive portfolio of products and services, including Smålån Service, Forbrukslån Service, and Refinansiering Service.
Provides information on small unsecured loans up to 70,000 kroner
Offers guidance on consumer loans for various personal needs
Advises on consolidating debts for better interest rates
Funding Insights of Althea Technologies
Althea Technologies has successfully raised a total of $23M through 1 strategic funding round. The most recent funding activity was a Series C round of $23 million completed in January 2007. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $23M
- Total Rounds 1
- Last Round Series C — $23M
- First Round $23M
(Jan 2007)
- Investors Count 1
All 1 funding rounds of Althea Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2007 | $23M | Series C | – | – |
2 investors in total: 2 institutional.
Investors in Althea Technologies
Althea Technologies has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Ajinomoto and Telegraph Hill Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science, medical device and healthcare companies | thpartners.net | San Francisco, United States | ||
Multi-category food and beverage products are manufactured globally. | 1909 | ajinomoto.com | Tokyo, Japan |
Investor details for Althea Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Althea Technologies
2 people are tracked at Althea Technologies (2 in leadership).
| Name | Role | Group |
|---|---|---|
Francois Ferre | Co-Founder & CEO | Leadership |
Taro Fujie | CEO | Leadership |
Complete people profiles for Althea Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Althea Technologies
3 dated milestones of Althea Technologies across 15 years, from founding to its latest funding, stage changes and deals.
- Founded Althea Technologies is founded.
- Funding First funding round of $23.0M.
- Exit Acquired by Ajinomoto.
Competitors of Althea Technologies
Althea Technologies has 3 listed competitors in our database, 3 of them funded. They include Nephron Pharmaceuticals, Kardigan and AmbioPharm.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nephronpharm.com | 1937 | Florida, Puerto Rico | $625M | 1,578 | Sterile pharmaceutical products are manufactured and contract services are provided. | |
| kardigan.bio | 2023 | San Francisco, United States | $554M | Biotech company developing personalized medicines for cardiovascular diseases | ||
| ambiopharm.com | 2006 | North Augusta, United States | $24M | 186 | CDMO and analytical services for peptide development are provided. |
Detailed competitors of Althea Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Althea Technologies
Websites that share an audience with Althea Technologies (altheatech.com).
Websites whose visitors overlap most with Althea Technologies. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| altheadx.com | 34% | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Althea Technologies (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Althea Technologies
Althea Technologies was founded in 1998 and raised its 1st funding round 9 years after it was founded.
Althea Technologies is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Francois Ferre is the CEO of Althea Technologies, as recorded in our data. They have also founded this company.
Althea Technologies is a funded company, having raised a total of $23M across 1 funding round to date. The company's 1st funding round was a Series C of $23M, raised on Jan 2007.
Althea Technologies was founded in 1998 in San Diego, United States, and operates in the pharmaceutical sector as a contract manufacturer and distributor of clinical drugs and vaccines. Services provided include aseptic syringe filling, lyophilization, release testing, clinical packaging, and stability programs, supporting various clinical needs in the industry.
Althea Technologies's top competitors include Nephron Pharmaceuticals, Kardigan and AmbioPharm.
Althea Technologies offers Smålån Service, Forbrukslån Service, and Refinansiering Service.
Althea Technologies has 2 investors. Key investors include Ajinomoto, and Telegraph Hill Partners.
Yes. Althea Technologies was acquired by Ajinomoto in March 2013.